Abstract
Liquid-based cytology (LBC) for cervical screening would benefit from laboratory practice guidelines that define specimen adequacy for reporting of slides. The evidence base required to define cell adequacy should incorporate both ThinPrep™ (TP; Hologic, Inc., Bedford, MA, USA) and SurePath™ (SP; BD Diagnostics, Burlington, NC, USA), the two LBC systems used in the UK cervical screening programmes. The objectives of this study were to determine (1) current practice for reporting LBC in England, Wales and Scotland, (2) a reproducible method for cell counting, (3) the cellularity of slides classified as inadequate, negative or abnormal and (4) the impact of varying cellularity on the likelihood of detecting cytological abnormalities. The study involved four separate arms to pursue each of the four objectives. (1) A questionnaire survey of laboratories was conducted. (2) A standard counting protocol was developed and used by three experienced cytopathologists to determine a reliable and reproducible cell counting method. (3) Slide sets which included a range of cytological abnormalities were each sent to three laboratories for cell counting to study the correlation between cell counts and reported cytological outcomes. (4) Dilutio...Continue Reading
References
Jan 1, 1990·Journal of Clinical Epidemiology·A R Feinstein, D V Cicchetti
Apr 2, 1988·British Medical Journal·G H AndersonO M Bennett
Jan 23, 1999·American Journal of Clinical Pathology·A A RenshawE S Cibas
Apr 23, 2002·JAMA : the Journal of the American Medical Association·Diane SolomonUNKNOWN Bethesda 2001 Workshop
Jul 31, 2002·Acta Cytologica·John W Bishop
Sep 25, 2002·Cytopathology : Official Journal of the British Society for Clinical Cytology·D N SlaterS Rice
Jul 19, 2003·BMJ : British Medical Journal·Thomas Ind
Aug 19, 2003·Acta Cytologica·Kimberley D StudemanMichael R Henry
Sep 27, 2003·Cytopathology : Official Journal of the British Society for Clinical Cytology·B Hoelund
Nov 26, 2003·Cellular Signalling·Parmesh DuttDeniz Toksoz
Aug 2, 2006·Cytopathology : Official Journal of the British Society for Clinical Cytology·F McQueen, E Duvall
Mar 30, 2007·CA: a Cancer Journal for Clinicians·Diane SolomonTimothy McNeel
Apr 24, 1942·Science·G N Papanicolaou
Jan 1, 2008·Obstetrics and Gynecology·Marc ArbynJohan Bulten
Oct 15, 2008·BMJ : British Medical Journal·Joakim DillnerUNKNOWN Joint European Cohort Study
Jul 30, 2009·BMJ : British Medical Journal·Peter SasieniJack Cuzick
Nov 7, 2009·Health Technology Assessment : HTA·H C KitchenerUNKNOWN ARTISTIC Trial Study Group
Feb 24, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ArbynL von Karsa
Sep 4, 2010·European Journal of Public Health·Fatemeh Asadzadeh VostakolaeiLambertus A L M Kiemeney
Apr 22, 2011·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Kyu-Won JungJin-Soo Lee
Jun 20, 2012·Cytopathology : Official Journal of the British Society for Clinical Cytology·A G SiebersJ Bulten
Jul 11, 2012·Cytopathology : Official Journal of the British Society for Clinical Cytology·N GuptaJ H F Smith
Aug 31, 2012·International Journal of Cancer. Journal International Du Cancer·Philippe Autier
Nov 23, 2012·Cytopathology : Official Journal of the British Society for Clinical Cytology·A UmanaA Kubba
Nov 24, 2012·Cytopathology : Official Journal of the British Society for Clinical Cytology·J H F Smith
Jun 4, 2013·Scottish Medical Journal·A GreenN P Cohen
Jul 23, 2013·Cytopathology : Official Journal of the British Society for Clinical Cytology·E Duvall
Citations
Jan 29, 2016·Cytopathology : Official Journal of the British Society for Clinical Cytology·L M SmartA Wilson
Aug 27, 2015·Health Technology Assessment : HTA·Susan GuthrieSteven Wooding
Jul 8, 2017·Cytopathology : Official Journal of the British Society for Clinical Cytology·M McMenaminR McKenna
Sep 14, 2017·CytoJournal·Sveinung Wergeland SørbyeYing Chen